ALX ONCOLOGY HOLDINGS INC (ALXO) Capital expenditures 2018–2025
ALX ONCOLOGY HOLDINGS INC (ALXO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$212,000FY2025 · since FY2018: $653,000 → $212,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $212,000 | -52.6% |
| FY2024 | $447,000 | -64.9% |
| FY2023 | $1.3M | -10.7% |
| FY2022 | $1.4M | +114.3% |
| FY2021 | $666,000 | +2048.4% |
| FY2020 | $31,000 | -91.2% |
| FY2019 | $353,000 | -45.9% |
| FY2018 | $653,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice